Anandamide is also a lipid mediator that functions as an endogenous ligand (a protein that binds to a recptor) by attaching itself to the body’s CB1 receptors, the primary molecular target that’s responsible for the pharmacological effects of THC. Anandamide was discovered in the early ‘90s by Dr. Raphael Mechoulam, who was known for his groundbreaking research and discovery of delta-9-THC while trying to figure out why our bodies contained cannabinoid receptors that are capable of binding with external cannabinoids such as CBD and THC.
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…
By gently heating your plant matter instead of setting it on fire, a vaporizer extracts…
For the past five years, Texas has lived in a strange legal limbo. The 2018…
Thirty years after Prop 215, the California State Fair crowned its first home-grow champion and…
Senate leaders released a stopgap that would push most of the federal hemp deadline to…